Evidence map›Paper›PMID 25367293›Full record

ArticleGenome research2015

Violation of the 12/23 rule of genomic V(D)J recombination is common in lymphocytes.

Nicholas J Parkinson, Matthew Roddis, Ben Ferneyhough, Gang Zhang, Adam J Marsden, Siarhei Maslau, Yasmin Sanchez-Pearson, Thomas Barthlott, Ian R Humphreys, Kristin Ladell and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Genome research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Nicholas J ParkinsonSystems Biology Laboratory UK, Abingdon, Oxfordshire OX14 4SA, United Kingdom;
Matthew RoddisSystems Biology Laboratory UK, Abingdon, Oxfordshire OX14 4SA, United Kingdom;
Ben FerneyhoughSystems Biology Laboratory UK, Abingdon, Oxfordshire OX14 4SA, United Kingdom;
Gang ZhangSystems Biology Laboratory UK, Abingdon, Oxfordshire OX14 4SA, United Kingdom;
Adam J MarsdenSystems Biology Laboratory UK, Abingdon, Oxfordshire OX14 4SA, United Kingdom;
Siarhei MaslauSystems Biology Laboratory UK, Abingdon, Oxfordshire OX14 4SA, United Kingdom; MRC Functional Genomics Unit, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3PT, United Kingdom;
Yasmin Sanchez-PearsonSystems Biology Laboratory UK, Abingdon, Oxfordshire OX14 4SA, United Kingdom;
Thomas BarthlottPaediatric Immunology, Department of Biomedicine, University of Basel and The Basel University Children's Hospital, 4058 Basel, Switzerland;
Ian R HumphreysInstitute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, United Kingdom;
Kristin LadellInstitute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, United Kingdom;
David A PriceInstitute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, United Kingdom; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA;
Chris P PontingMRC Functional Genomics Unit, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3PT, United Kingdom;
Georg HollanderPaediatric Immunology, Department of Biomedicine, University of Basel and The Basel University Children's Hospital, 4058 Basel, Switzerland; Developmental Immunology, Weatherall Institute of Molecular Medicine and Department of Paediatrics, University of Oxford, Oxford OX3 9DS, United Kingdom;
Michael D FischerSystems Biology Laboratory UK, Abingdon, Oxfordshire OX14 4SA, United Kingdom; Department of Oncology, Division of Cellular and Molecular Medicine, St. George's, University of London, London SW17 0QT, United Kingdom.
Cardiff University · GBUniversity of Basel · CHUniversity of Oxford · GBNational Institutes of Health · USSt George's, University of London · GB

Funding

Medical Research Council MC_U137761446Medical Research Council MC_UU_12021/1Wellcome Trust 100326
6 · The paper itself

Abstract

V(D)J genomic recombination joins single gene segments to encode an extensive repertoire of antigen receptor specificities in T and B lymphocytes. This process initiates with double-stranded breaks adjacent to conserved recombination signal sequences that contain either 12- or 23-nucleotide spacer regions. Only recombination between signal sequences with unequal spacers results in productive coding genes, a phenomenon known as the "12/23 rule." Here we present two novel genomic tools that allow the capture and analysis of immune locus rearrangements from whole thymic and splenic tissues using second-generation sequencing. Further, we provide strong evidence that the 12/23 rule of genomic recombination is frequently violated under physiological conditions, resulting in unanticipated hybrid recombinations in ∼10% of Tcra excision circles. Hence, we demonstrate that strict adherence to the 12/23 rule is intrinsic neither to recombination signal sequences nor to the catalytic process of recombination and propose that nonclassical excision circles are liberated during the formation of antigen receptor diversity.

Indexed as

GenomicsV(D)J RecombinationAnimalsCell DifferentiationGene RearrangementGenes, RAG-1HumansLymphocytesMiceMice, KnockoutModels, BiologicalSequence Analysis, DNA

Identifiers

PMID25367293
PMCPMC4315296
OpenAlexW2098526339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.